| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |